title: Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study.
abstract: OBJECTIVE
  To establish how far liposomal copper/zinc superoxide dismutase (Cu/Zn-SOD) and manganese superoxide dismutase (Mn-SOD), respectively, reduce radiation-induced fibrosis (RIF), using a well-characterized pig model of RIF permitting the design of a controlled laboratory experiment.
  
  
  METHODS
  In this model of acute localized gamma irradiation simulating accidental overexposure in humans, three groups of five large white pigs were irradiated using a collimated 192Ir source to deliver a single dose of 160 Gy onto the skin surface (100%) of the outer side of the thigh. A well-defined block of subcutaneous fibrosis involving skin and skeletal muscle developed 6 months after irradiation. One experimental group of five pigs was then injected i.m. with 10 mg/10 kg b.wt. of Cu/Zn-SOD, twice a week for 3 weeks, and another experimental group of five was injected with 10 mg/10 kg b.wt. of Mn-SOD, three times a week for 3 weeks. Five irradiated control pigs were injected with physiological serum. Animals were assessed for changes in the density of the palpated fibrotic block and in the dimensions of the projected cutaneous surface. Block depth was determined by ultrasound. Physical and sonographic findings were confirmed by autopsy 12-14 weeks after completing SOD injections. The density, length, width, and depth of the fibrotic block, and the areas and volume of its projected cutaneous surface were compared before treatment, 1, 3, and 6 weeks thereafter, and at autopsy, 12-14 weeks after treatment ended.
  
  
  RESULTS
  The experimental animals exhibited no change in behavior and no abnormal clinical or anatomic signs. Whether they were given Cu/Zn- or Mn-SOD, significant and roughly equivalent softening and shrinking of the fibrotic block were noted in all treated animals between the first week after treatment ended and autopsy, when mean regression was 45% for length and width, 30% for depth, and 70% for area and volume. Histologic examination showed completely normal muscle and subcutaneous tissue surrounding the residual scar. This replacement of scar tissue by normal tissue in experimental animals and the 50% decrease in the linear dimensions of the scar were comparable to the results obtained in previous clinical studies and highly significant compared to the clinical and autopsy results for the control animals.
  
  
  CONCLUSIONS
  Our results are striking and comparable to the results obtained in our previous clinical study after liposomal Cu/Zn-SOD treatment. To our knowledge, this is the first time that two agents have been shown to reverse the radiation-induced fibrotic process in experimental animals and to permit the regeneration of normal tissue in a zone of well-established postirradiation fibrosis.
authors.affiliation: CEA-DSV-DRR-Laboratoire de Radiobiologie Appliquée, CEA-Saclay, Gif sur Yvette, France.
authors.forename: J L
authors.initials: JL
authors.lastname: Lefaix
authors.forename: S
authors.initials: S
authors.lastname: Delanian
authors.forename: J J
authors.initials: JJ
authors.lastname: Leplat
authors.forename: Y
authors.initials: Y
authors.lastname: Tricaud
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Nimrod
authors.forename: F
authors.initials: F
authors.lastname: Baillet
authors.forename: F
authors.initials: F
authors.lastname: Daburon
mesh_terms: D000818:Animals; D005260:Female; D005355:Fibrosis / Q000188:drug therapy; D008081:Liposomes; D011833:Radiation Injuries, Experimental / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology* / Q000528:radiation effects; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D013482:Superoxide Dismutase / Q000627:therapeutic use*; D013552:Swine
chemical_list: D008081:Liposomes; D013482:Superoxide Dismutase